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Abstract The use of matrix-assisted laser desorptionlionization 
mass spectrometry (MALDI-MS) in identifying proopiomelano- 
cortin (POMC) processing products in melanotrope cells of the 
pituitary intermediate lobe of Xenopus faevis was explored. Mass 
spectra were obtained with such a high sensitivity of detection that 
the peptides could be identified in a single melanotrope cell. In 
addition to known POMC processing products of the Xenupus 
melanotrope cell, t he presence of previously unidentified POMC- 
derived peptides was demonstrated. Together these POMC proc- 
essing products accounted for the entire length of the POMC 
precursor. Furthermore, Xenopus possesses two genes for 
POMC and the sensitivity and accuracy of the MALDI-MS 
technique allowed identification of processing products of both 
the POMC, and POMCa gene. In addition, differences were 
obtained between the mass spectra of melanotrope cells from 
Xenopus laevis adapted to different conditions of background 
illumination. These results show that MALDI-MS is a valuable 
tool in the study of the expression of peptides in single (neuroen- 
docrine) cells. 
Key words: Matrix-assisted laser desorption/ionization mass 
spectrometr; Proopiomelanocortin; Melanotrope cell; 
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1. Introduction 
In amphibians, the melanotrope cells of the intermediate lobe 
of the pituitary gland secrete a melanotropic peptide, a-mela- 
nocyte-stimulating-hormone (a-MSH), which causes pigment 
dispersion in dermal melanophores. Thus, the pituitary mela- 
notropes play a pivotal role in the process of skin color adapta- 
tion. In lower vertebrates, as in mammals, a-MSH originates 
from a high molecular weight precursor protein, proopiomela- 
nocortin (POMC). Based on thye cDNA nucleotide sequence, 
the complete amino acid sequence of POMC has been deter- 
mined in various mammalian [l-6] and non-mammalian verte- 
brates [7-lo]. THrough tissue-specific processing POMC can 
*Corresponding author. Fax: (31) (24) 36522714. 
Abbreviations: AC, acetylated; AJP, acidic joining peptide; ACTH, 
adrenocorticotropic hormone; CLIP, corticotropin-like intermediate 
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generate a number of bioactive peptides including adrenocorti- 
cotropic hormone (ACTH), a-, /?- and y-MSH, &lipotropin 
(/?-LPH) and p-endorphin [ 111. 
The melanotrope cells of the amphibian Xenopus laevis are 
specialized in producing and secreting POMC-derived prod- 
ucts. Although in some studies MSH peptides and endorphin 
end products [12-141 have been identified, little is known about 
the complete profile of POMC processing products within the 
melanotrope cell. The complexity of the POMC precursor 
makes identification of all processing end products using tran- 
ditional biochemical methods extremely difficult. The common 
practice of analysing neuropeptides by radioimmunoassay be- 
comes arduous when applied to entire profiles. Moreover, this 
method can only be used for known peptide families. The intro- 
duction of high-mass mass spectrometric techniques and parti- 
cle-induced desorption/ionization methods for analysing intact 
biopolymers [15-l 71 has resulted in the manufacturing of mass- 
specific analysers that (1) can detect peptides regardless of 
provenance and composition, (2) are fast and (3) can be used 
to characterize complete profiles in mixtures of different pep- 
tides [ 18,191. One of these techniques is the matrix-assisted laser 
desorptionlionization mass spectrometry (MALDI-MS) [20- 
221 which enabled the measurement of complete peptide pro- 
files in single cells without prior peptide purification. For pro- 
teins of which the sequence is (largely) known, mass spectrom- 
etry permits a rapid, detailed confirmation of the sequence and 
the identification of possible protein modifications, e.g. acetyl- 
ation, amidation, glucosylation and phosphorylation [23]. In 
the case of the Xenopus melanotrope cell, the majority of the 
peptides produced are derived from POMC [24]. The complete 
amino acid sequence of this precursor has been deduced from 
its nucleotide sequence [7]. Xenopus possesses two different 
POMC genes, named POMC, and POMC,, which are similar 
(but not identical) in their amino acid sequences (251. MALDI- 
MS would be an appropriate method to characterize the full 
peptide profile resulting from the processing of POMC, and 
POMC,. Furthermore, because melanotrope cells of black- 
background adapted Xenopus laevis are very active in synthesiz- 
ing and processing of POMC whereas melanotrope cells from 
white-adapted Xenopus serve as storage cells with an inactive 
biosynthetic apparatus [26,27], with MALDI-MS the hypothe- 
sis could be tested that cells from black-adapted Xenopus con- 
tain more (larger) POMC processing intermediates than cells 
of white-adapted Xenopus. The purpose oft his study was (1) 
to identify the different POMC (POMC, and POMC,) process- 
ing end products and (2) to elucidate possible differences in the 
contents of melanotrope cells from animals adapted to different 
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environmental light conditions. This was done by MALDI-MS, 
using single Xenopus melanotrope cells to prevent interference 
with other cell types present in the pituitary gland. 
2. Materials and methods 
2.1. Animals 
Adult Xenopus laevis with a weight of approximately 35 g were 
obtained from our laboratory stock. Toads were kept under constant 
illumination on a black or a white background for at least 3 weeks at 
22°C. They were fed trout pellets (Trouvit, Trouw, Putten, The Nether- 
lands) once a week. 
2.2. Preparation of single cells 
The melanotrope cells of 8 animals were isolated from the pituitary 
neurointennediate lobe as described previously [28], with minor 
changes. In short, animals were anaesthetized for 15 min in a solution 
containing 0.1% MS222 (Sigma; St. Louis, MO, USA) and 0.15% 
NaHCO, (pH 6.8). After perfusing the animal with Xenopus Ringer’s 
solution, containing 112 mM NqaCl, 2 mM KCl, 2 mM CaCl, and 15 
mM HEPES (Calbiochem; La Jolla, CA, USA; pH 7.4) to remove 
blood cells, lobes were dissected and incubated for 45 min in Ringer’s 
solution without CaCl, to which 0.25% (w/v) trypsin (Gibco, Ren- 
frewshore, UK) had been added. Cells were subsequently dispersed in 
Ringer’s solution by gentle trituration of the lobes with a siliconized 
Pasteur’s pipette. The cells were readily identified on the basis of their 
characteristic round shape and used immediately for mass spec- 
trometry. 
3 
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2.3. Sample preparation 
Before MALDI-MS only minimal sample preparation was necessary. 
The matrix used was 2,5-dihydroxobenzoic acid (DHB; Aldrich 
Chemie, Steinheim, Germany) dissolved at a concentration of 10 mg/ml 
in 0.1% trifluoroacetic acid (TFA; Merck, Darmstadt, Germany). After 
deposition of 1 yl of the matrix on a stainless steel target, the cells were 
placed in the matrix solution. The sample was dried in a cold air stream 
before loading into the mass spectrometer. Calibration was performed 
using a mixture of bovine insulin and horse cytochrome c (Sigma). The 
acid matrix used to retain the products directly from the melanotrope 
cells produced sufficient ions to eliminate purification artifacts, 
2.4. Mass spectrometry 
The mass spectrometer used was a VISION 2000 (Finnigan MAT, 
Bremen, Germany). This is a reflectron time-of-flight (TOF) laser 
desorption instrument equipped with a nitrogen laser at 337 nm. The 
laser beam was focused by a quartz lens system to a spot size of 70 pm 
in diameter. The ions generated were accelerated to a potential of 5 kV 
in the ion source and post-accelerated by a conversion dynode to a 
potential of 20 kV. The effective drift length of the instrument is 1.7 m. 
Ions were detected by a secondary electron multiplier and the signal was 
amplified and digitized by a high speed transient recorder linked to a 
486 personal computer. Molecular weight data were collected and com- 
pared with computer-analysed POMC precursor fragments with known 
or predicted molecular weight, using the ‘find mass’ program (MacPro- 
Mass, Beckman Research Institute of the City of Hope, Duarte, CA, 
USA). Mass measurements up to 5 kDa were reliable up to f 3 Da. 
Therefore, a small search window can be used, resulting in fewer 
matches and consequently less ambiguity in identification. 
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Fig. 1. Representative example of MALDI mass spectra from freshly isolated, single melanotrope cell of Xenopus laevis. Arrows indicate the position 
of identified POMC processing products (see Table 1). The spectra represent unprocessed data accumulated from 20 single-shot acquisitions without 
any filtering or backgruond substraction. (A) Spectrum from a melanotrope cell derived from a white-background adapted animal. (B) Spectrm from 
a melanotrope cell of a black-background adapted animal. Peak 4 was present as a small peak partially overlapping with peak 3 and peak 13 was 
not always detected in the spectrum. At higher resolution the presence of these products was clearly visualized. 
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Fig. 2. Schematic representation of the POMCA precursor of the amphibian Xenopus laevis. The structure of the POMC gene was deduced from 
nucleotide sequence analysis [7]. Positions of amino acid differences between POMCA and POMCs are indicataed by filled arrows and the single amino 
acid addition in POMCa is indicated by an open arrow. The position of the glycosylation site is shown by the open circle. Sites where two or more 
basic amino acids occur are boxed. Processing products formed via processing at dibasic amino acids are indicated by horizontal lines. AA = amino 
acid. 
3. Results and discussion 
This study is based on the rationale that molecular weight 
information is sufficiently specific to tentatively identify all 
peptides that are either known to be present or can be predicted 
to occur in a given cell or tissue. This approach reduces the 
number of peptides that have to be analysed by more rigorous, 
but also more laborious and time-consuming, methods. Predic- 
tion is on the basis of ‘classical’ precursor processing at consec- 
utive basic amino acids or by processing at ‘consensus’ se- 
quence sites [29-3 I]. With single cells, especially with a homo- 
geneous cell suspension such as the melanotrope cells of Xen- 
opus luevis, that only express one major type of precursor mol- 
ecule, mass accuracy becomes less important. 
3.1. Complete mass profiles of melanotrope cells 
The overview mass spectra of a single melanotrope cell from 
both white- and black-background adapted Xenopus laevis re- 
vealed 20 to 25 significant ions (Fig. 1). Clean and reproducible 
mass spectra were obtained up to a molecular mass of 10,000 
Da. Mass accuracy for the peptides was in most cases better 
than + 1 Da. The peaks with larger deviation may include unre- 
solved components. The width of the peaks at higher mass 
slightly decreases accuracy. 
The molecular weight data obtained in this study immedi- 
ately pinpointed a number of the reported processing products 
of Xenopus POMC [12,13,32], ultimately accounting for the 
entire length of the POMC precursor (see Table 1, Fig. 2). Both 
desacetyl-a-MSH as well as a-MSH, /3-MSH and lys-y,-MSH 
could readily be identified. Howeiver, the a-MSH peak was 
very small compared to the desacetyl-a-MSH peak. This abun- 
dance ofg the desacetyl-a-MSH peak over the a-MSH peak is 
in line with results obtained using radioimmunoassay for a- 
MSH [14,33,34]. As expected, only one ion was observed for 
each of the products, since these products show no difference 
in molecular weight whether derived from POMC, or POMC,. 
The a,N-acetylated-&endorphin{ l-8) (POMC 229-236) was 
mainly present as sodium and potassium ions, resulting in shifts 
of 22.0 Da and 38.1 Da for the sodium and potassium ion, 
respectively. Thus, the measured molecular weight of this pep- 
tide differs from the calculated molecular weight showing shifts 
from 944.1 to 966.1 and 982.2, respectively. This result was 
confirmed by running synthetic a,N-acetyl-p-endorphini l-8) 
(POMC 229-236) under the same conditions which resulted in 
the apperance of the 966.1 Da and 982.2 Da products, in the 
absence of the 944.1 Da H’-ion. Only small peaks were ob- 
served for all acetylated endorphins (viz. a,N-acetyl-/I-endor- 
phin{ l-8}, (l-27) and (l-31)). Because it is known that the 
Xenopus melanotrope cells contain high amounts of a,N-acetyl- 
/3-endorphin{ l-8) (POMC 229-236) [13], acetylation of these 
Table I 
Summarv of mass data of identified POMC nrocessinr! nroducts obtained from XenoDus melanotrone cells 
Peptide Peak Nr. POMC,(POMC,) [M + H’lc MALDI-MS A 
N-terminus 2 2634 1070.2 1069.4 - 0.8 
N-terminus 14 2673 5139.7 (5183.9) 5139.1 (5182.7) - 0.6 (- 1.2) 
N-terminus 15 26101 ST > 10,000 
Lys-y,-MSH 5 75586NH, 1657.0 1656.0 - 1.0 
Lys-y,-MSH 13 75-101 ST 5006.8 (5050.2) - 1.8 (- 0.6) 
AJP 12 104137 (104-138) 3885.1 (4042.2) 3882.7 (4041.5) - 0.1 (- 0.7) 
Des-Ac-a-MSH 3 140_152NH, (141I153NH2) 1607.9 1607.0 - 0.9 
a-MSH 4 146152NHz (141l153NHZ) 1649.9 1648.9 - 1.0 
CLIP-fragment 6 1577172 (158-173) 1818.0 1817.2 - 0.8 
CLIP 8 157-178 (158-179) 2538.8 (2522.8) 2537.9 (2522.4) - 0.9 (- 0.4) 
N-fragment 9 181-205 (182-206) 2895.1 (2965.1) 2897.2 (NI) + 2.1 (NI) 
/I-MSH 7 210-226 (21 l-227) 2100.3 2099.7 - 0.6 
Ac+Ep{ l-8) 1 229-236 (230-237) 944.1 966.4 (ST) + 0.3 (ST) 
AC+-Ep{ 1-27 } 10 2299255 (230-256) 3125.6 (3139.6) 3123.6 (3139.1) - 2.0 (- 0.5) 
AC-/~-Ep{ l-31 } 11 229-259 (23G260) 3567.2 (3566.2) 3566.8 (3564.8) - 0.4 (- 1.4) 
Peak numbers are related to the peaks as shown in Fig. 1. Amino acids l-25 of the POMC precursor comprises the signal peptide which is generally 
not found. The complete POMC,., precursor comprises 259 amino acids (260 for POMC,; [25]). The position of the peptides within the precursor 
and the calculated average molecular mass of POMC, (and POMC,) processing products have been indicated, as well as the molecular weight products 
found by MALDI-MS. The difference between calculated average mass and measured molecular mass of the protonated ions is indicated by A. 
AJP = acidic joining peptide, AC = acetyl, NI = not identified, ST = see text. 
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Fig. 3. MALDI mass spectrum from a single melanotrope cell confirm- 
ing the presence of both POMC, and POMC, gene products. (A) 
Corticotropin-like intermediate peptide from POMC, 
([M + H’], = 2538.8) and from POMC, ([M + H’], = 2522.8). (B) The 
N-terminal peptide (POMC 2673) derived from POMC, 
([M + H’], = 5139.7) and POMC, ([M + H’], = 5183.9). The spectra 
represent unprocessed data accumulated from 10 single-shot acquisi- 
tions without any filtering or background substraction. 
endorphins may interfere with the matrix or with the ionization/ The usefulness of the ‘find mass’ program for the recognition 
detection possibility of the mass spectrometer. Possibly due to of unexpected peptides was demonstrated for C-terminally 
the complexity of the peptide contents of the melanotrope cell shortened forms of CLIP, of the so called N-fragment (POMC 
the mass spectrometric signal of these peptides is suppressed 181-207), and of the N-terminal peptide (POMC 26-73). On the 
and thus prohibits detection of all analytes. The mechanism of basis of the computer analysis the C-terminally truncated CLIP 
this suppression is still unknown [35]. Although the absence of (POMC 157-172) is the peptide with amolecular weight of 
a signal does not prove that a peptide is not there, the absence 1817.2 (peak 6). Furthermore, C-terminally shortened products 
of non-acetylated endorphins in the melanotrope cells confirms of the N-terminal and the N-fragment were found to fit ions 
previous findings [14,36]. These results confirm the observa- (peak 2 and 9) in the mass spectrum. CLIP, the N-terminal 
tions concerning the spatial difference in acetylation of a-MSH peptide and the N-fragment are both acidic and contain high 
and endorphins, while the endorphins are rapidly acetylated molecular percentages of proline, glutamic acid, aspartic acid 
after synthesis (so, no non-acetylated endorphins can be found and threonine. This fact has been linked to fast proteolytic 
within the cell), acetylation of desacetyl-a-MSH occurs at the degradation in vivo [45] and explains the presence of the trun- 
moment of secretion, which explains the small amount of a- cated forms of the N-fragment, the N-terminal and CLIP found 
MSH present within the cell [32-34,361. in this study. 
3.2. D@rent POMC, and POMC, processing end products 
Several peptide products, unique to either the POMC, or the 
POMC, gene, were found. Only small differences in the height 
of the peaks of POMC, and POMC, end products were visible, 
indicating similar amounts of POMC, and POMC, end prod- 
ucts and a similar processing. This is in agreement with the 
biosynthesis and the level of expression of the two POMC genes 
[37]. The corticotropin-like intermediate peptides (CLIPS) de- 
rived from POMC, and POMC, have a difference in molecular 
mass of only 18 Da, but both peptides were clearly present 
(Fig. 3A). Interestingly, no evidence for posttranslational mod- 
ification of this product in Xenipus laevis melanotropes could 
be obtained, although it has been shown that both rat and 
human CLIP can be phosphorylated as well as glycosylated 
[38,39]. Two different peaks were also observed to match the 
N-terminal 26-73 peptide of the two POMC genes (Fig. 3B). 
These peptides were the most favourable matches for the ions 
seen, with an average molecular weight of 5139.1 and 5182.7. 
Recent biosynthesis studies have shown that this N-terminal 
peptide is a secretory product rapidly formed from a larger 
y-MSH-containing POMC product [40]. 
3.3. ly-MSH peptides in Xenopus melanotropes 
The POMC precursor protein of Xenopus laevis contains 
only one glycosylation site, which is present in the y-MSH 
region (Fig. 2) []25]. Nevertheless, cleavage at this site results 
in several peptide products containing the glycogroup (Lys-y,- 
MSH and the N-terminal peptides harbouring this y-MSH). 
Since glycopeptides are not always seen in mass spectrometr 
[18] and since the carbohydrate structures of the intermediate 
glycopeptides are not known, the identification of these pep- 
tides is not straight forward. Nevertheless, both POMC, Lys- 
?I,-MSH and POMC, Lys-y,-MSH have been isolated and their 
molecular weights identified by electrospray mass spectrometr 
[40]. Although only small peaks were found in the melanotrope 
cells, the molecular weights for the Lys-y,-MSH peptides have 
now been confirmed by MALDI-MS. Consistent with earlier 
reports [4143] we observed Lys-y-MSH and not y-MSH. Un- 
less flanked by a proline, all basic amino acids are generally 
removed after cleavage of the neuropeptide precursors at basic 
sites [31,44]. It remains an unanswered question as to why the 
cleavage procedure for Lys-y-MSH is so different from that 
occurring at other basic sites. 
3.4. Unexpected POMC peptides 
3.5. Unidentified products 
Some peaks could not be identified as POMC processing 
products by MALDI-MS (MW 1388.9, 2002.2, 2422.3). Possi- 
bly, these peaks represent posttranslationally modified POMC 
end products (e.g. by amidation, acetylation, phosphorylation 
or glycosylation). Alternately, they may be non-POMC pep- 
tides produced by the Xenopus melanotrope cell. The post 
source decay technique, which is currently in a developmental 
stage, will probably allow the extraction of sequence informa- 
tion from these products [46]. Other POMC peptides deduced 
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by computer analysis matching ions present in the spectrum 
were judged by us to be poor candidates either because they (1) 
contain dibasic cleavage sites not expected to survive in the 
intermediate pituitary or (2) their processing would require the 
unlikely cleavage of a dibasic cleavage site next to a proline. 
3.6. Background adaptation 
Although the MALDI-MS profiles of cells derived from 
black-background adapted animals (Fig. 1A) and those of 
white-background adapted animals (Fig. 1 B) showed little 
qualitative difference, the relative intensity of several peaks was 
quite different. Major differences were found for instance in the 
higher molecular weight region, where the 10 kDa product 
(peak 1.5) was more pronounced in cells derived from black 
animals compared to the peak in cells of white-adapted toads. 
This ion might be identified as a POMC processing product. 
The N-terminal processing product of POMC (26-101) con- 
tains the Lys-y,-MSH and has a molecular weight of 10 kDa. 
Previous findings have reported the existence of large interme- 
diates in the processing of POMC to its end products in mela- 
notrope cells from black-background adapted Xenopus [24] and 
such a N-terminal product has been identified as a major proc- 
essing product on SDS gel electrophoresis [41]. It seems likely 
that the 10 kDa ion is this product. Some other products in the 
mass profile with a lower molecular weight (peak 2 and an 
unidentified molecular ion at m/z 1388.9) were more pro- 
nounced in melanotrope cells of white-adapted Xenopus than 
in cells of black-adapted animals. The physiological signifi- 
cance of this difference in processing end products is not 
known. However, these findings are in agreement with the idea 
that melanotropes of black-background adapted animals are 
very active in the biosynthesis and processing of POMC and 
thus will contain larger intermediates, while melanotropes of 
white-backgruond adapted animals serve as storage cells, con- 
taining completely processed POMC end products [14,27,35]. 
3.7. Conclusions 
Single pituitary melanotrope cells can be efficiently charted 
by MALDI-MS and reveal a complete spectrum of the POMC- 
derived peptides. Although the samples are initially in a physi- 
ological environment, neither sample pretreatment nor separa- 
tion steps are necessary. This offers a fast screening which is 
minimizing artifacts caused by extraction or separation proce- 
dures of conventional methodologies, and offers the possibility 
to directly mass analyse proteins present in naturally occurring 
biological fluids. All previously identified and several new 
POMC end products in melanotrope cells of Xenopus laevis 
were identified by the MALDI-MS method. In addition, the 
differences in processing end products of POMC, and POMC, 
could be resolved. While little can be said of the absolute con- 
centration of the peptides in the profiles, clear differences be- 
tween the relative intensities of the peaks show that MALDI- 
MS can be used to demonstrate different peptide contents in 
melanotrope cells from animals under different physiological 
conditions. 
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